Evolution of the Average Target: Philips NV

Evolution of the Target Price: Philips NV

Changes in Analyst Recommendations: Philips NV

0b1eb2569e897359e692bd47.lyYpWnYdFstLLU74KuqWwugJ8aCEnN-mL2rwEVDeDKU.5nMZEhdSUKcNWx-dYZzvsaN_nO213oDpHSalfjuIY_z0U3kdIFhdoApCCw~fd266d668b7d38e4cdb5246430615393
08-03 UBS Downgrades Koninklijke Philips to Neutral, Cuts PT MT
08-03 PHILIPS NV : UBS revises his opinion and turns to Neutral ZD
07-31 RBC Tweaks Philips Forecast After Q2 Results; Sector Perform Maintained MT
07-30 PHILIPS NV : Deutsche Bank reaffirms its Neutral rating ZD
07-29 PHILIPS NV : Receives a Buy rating from DZ Bank ZD
07-29 PHILIPS NV : Bernstein sticks Neutral ZD
07-29 PHILIPS NV : JP Morgan reiterates its Neutral rating ZD
07-28 Koninklijke Philips NV: Caution in Q3 overshadows the underlying business strength, presenting a buying opportunity Alphavalue
07-28 PHILIPS NV : RBC reiterates its Neutral rating ZD
07-28 PHILIPS NV : Bernstein remains Neutral ZD
07-28 PHILIPS NV : JP Morgan reaffirms its Neutral rating ZD
07-16 MedTech facing a three-front squeeze Alphavalue
07-07 PHILIPS NV : JP Morgan gives a Neutral rating ZD
07-07 PHILIPS NV : Jefferies is Neutral ZD
07-02 Bernstein: Philips Still On Track for FY26 Goals Despite Expected Q2 Margin Dip MT
06-30 PHILIPS NV : Bernstein remains Neutral ZD
06-30 RBC Tweaks Estimates for Philips on Currency Moves, Share Issuance; Sector Perform Rating Kept MT
06-25 PHILIPS NV : Buy rating from Goldman Sachs ZD
06-23 PHILIPS NV : JP Morgan reiterates its Neutral rating ZD
05-14 Philips Estimates Adjusted as RBC Notes Q2 Margin Headwinds MT
05-14 PHILIPS NV : Jefferies remains Neutral ZD
05-11 DZ Bank Sticks With a Buy on Philips Zonebourse
05-11 PHILIPS NV : DZ Bank reiterates its Buy rating ZD
05-11 Bernstein Keeps Philips at Market-Perform After Q1 Top-line Beat; EPS Forecasts Trimmed MT
05-08 KBC Securities Upgrades Philips to Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.3%
+11.33%
+25.99%
+27.13%
+12.53%
+14.01%
+9.14%
+6.52%
+14.95%
Average +14.21%
Weighted average by Cap. +13.90%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
23.13EUR
Average target price
27.00EUR
Spread / Average Target
+16.71%
High Price Target
35.00EUR
Spread / Highest target
+51.32%
Low Price Target
23.40EUR
Spread / Lowest Target
+1.17%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
DZ BANK Aristotelis Moutopoulos
alphavalue Anas Patel
JPMORGAN David Adlington
BERNSTEIN RESEARCH Susannah Ludwig
RBC Natalia Webster
JEFFERIES Julien Dormois
GOLDMAN SACHS Richard Felton
KBC Securities
BARCLAYS Hassan Al-Wakeel
RBC Capital Markets
DEUTSCHE BANK RESEARCH Falko Friedrichs
BNP Paribas
AlphaValue/Baader Europe
Jefferies & Co.
Morningstar
HSBC
MORGAN STANLEY Robert Davies
Societe Generale
JPMorgan Chase
Credit Suisse
DEUTSCHE BANK Falko Friedrichs
KEPLER CHEUVREUX Oliver Reinberg
Citigroup
BERENBERG Scott Bardo
ING Group
Deutsche Bank Securities
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
23.13EUR
Average target price
27.00EUR
Spread / Average Target
+16.71%

Quarterly revenue - Rate of surprise